How much debt does AIM ImmunoTech have?

AIM ImmunoTech had total debt of $4.90M as of Mar 31, 2026, against $993.00K in cash and short-term investments. Total debt was $2.70M a year earlier.

What are AIM ImmunoTech's total assets?

AIM ImmunoTech reported total assets of $5.78M as of Mar 31, 2026, down 32.8% from $8.61M a year earlier. Total liabilities were $15.56M.

What is AIM ImmunoTech's shareholders' equity?

AIM ImmunoTech's shareholders' equity was negative at −$9.78M as of Mar 31, 2026, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

AIM ImmunoTech (AIM) Balance Sheet: Assets & Liabilities

AIM ImmunoTech Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for AIM ImmunoTech Inc. (AIM) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Mar 2023	Dec 2022	Mar 2022	Dec 2021	Mar 2021	Mar 2020	Mar 2019	Dec 2017
Current Assets
Cash and Cash Equivalents	0.93	2.99	1.70	5.44	5.44	27.05	27.05	32.09	32.09	38.50	1.47	0.30	1.41
Short-Term Investments	0.06	0.06	2.28	7.63	7.63	7.14	7.14	16.18	16.18	0.50	7.31	1.53	0.70
Cash & Short-Term Investments	0.99	3.05	3.98	13.07	13.07	34.19	34.19	48.27	48.27	39.00	8.78	1.83	2.11
Accounts Receivable	0.01	0.01	0.00	1.18	1.18	1.68	1.68	1.64	-	1.12	0.82	1.09	0.02
Inventory	0.00	-	0.00	-0.30	-	0.00	-	0.00	-	0.00	0.00	0.00	0.00
Other Current Assets	2.30	0.24	0.20	0.60	0.30	0.46	0.46	0.30	0.30	0.18	0.85	0.88	1.37
Total Current Assets	3.30	3.30	4.18	14.56	14.56	36.32	36.32	50.21	50.21	40.31	10.45	3.80	3.51
Non-Current Assets
Property, Plant & Equipment (Net)	0.45	0.45	0.73	0.82	0.82	1.02	1.02	4.20	4.20	6.65	7.27	7.78	8.59
Long-Term Investments	0.00	-	0.00	0.00	-	0.00	-	-25.02	-	15.38	-45.10	-40.29	0.00
Intangible Assets	1.66	1.66	2.59	2.31	2.31	1.94	1.94	1.97	1.97	1.50	1.15	0.91	0.86
Other Non-Current Assets	0.38	0.38	1.11	1.69	1.69	1.20	1.20	1.32	1.32	0.12	1.35	1.35	1.26
Total Non-Current Assets	2.49	2.49	4.43	4.83	4.83	4.17	4.17	7.49	-	70.71	9.77	10.05	10.70
Total Assets	5.78	5.78	8.61	19.38	19.38	40.49	40.49	57.70	57.70	111.02	20.22	13.85	14.21
Current Liabilities
Accounts Payable	1.63	1.63	6.38	6.44	6.44	0.38	0.38	0.20	0.20	0.38	0.47	0.68	0.74
Short-Term Debt	3.80	3.55	2.31	0.22	-	0.18	-	0.04	-	0.28	0.25	3.61	0.00
Current Portion of Long-Term Debt	-	3.55	2.31	-	-	-	-	-	-	-	-	-	-
Accrued Liabilities	-	0.80	0.61	-	1.57	-	0.81	-	0.44	-	-	-	-
Other Current Liabilities	0.80	-	0.61	1.99	-	0.81	-	0.44	-	0.44	0.40	1.01	1.97
Total Current Liabilities	6.22	6.22	9.54	8.65	8.65	1.36	1.36	0.67	0.67	1.10	1.13	5.29	2.71
Non-Current Liabilities
Long-Term Debt	1.10	0.93	0.40	0.50	0.50	0.66	0.66	0.11	-	2.01	6.13	2.32	1.84
Deferred Tax Liabilities	0.00	-	0.00	0.00	-	0.00	-	23.71	-	46.44	44.56	40.29	0.00
Other Non-Current Liabilities	8.24	8.24	0.00	0.00	-	0.00	-	0.04	0.04	0.18	0.06	1.06	0.96
Total Non-Current Liabilities	9.34	9.34	0.40	0.50	0.50	0.66	0.66	0.15	0.15	48.63	6.19	3.38	2.80
Total Liabilities	15.57	15.57	9.93	9.15	9.15	2.02	2.02	0.82	0.82	49.73	7.31	8.67	5.50
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.05	0.05	0.05	0.05	0.05	0.05	0.04	0.01	0.00	0.03
Retained Earnings	-440.79	-440.79	-426.83	-409.51	-409.51	-380.55	-380.55	-361.10	-361.10	-341.97	-328.11	-318.57	-308.76
Accumulated Other Comprehensive Income	0.00	-	0.00	0.00	-	0.00	-	0.00	-	-0.05	-8.55	0.00	0.01
Additional Paid-in Capital	431.00	431.00	425.51	419.00	419.00	418.27	418.27	417.22	-	402.54	340.23	323.75	317.42
Shares Outstanding	-	3.07	0.66	-	0.49	-	0.48	-	-	-	-	-	-
Total Stockholders' Equity	-9.78	-9.78	-1.32	10.23	10.23	38.47	38.47	56.88	56.88	61.29	12.91	5.17	8.70
Total Liabilities & Equity	5.78	5.78	8.61	19.38	19.38	40.49	40.49	57.70	-	111.02	20.22	13.85	14.21

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

AIM ImmunoTech Balance Sheet Analysis

Frequently Asked Questions About AIM ImmunoTech Balance Sheet